Form 4: Cognizant Director Mackay Jr. Receives Additional Restricted Stock Units Through Dividend Equivalent Rights

Sentiment:

SEC Form 4


Director Leo S. Mackay Jr. of Cognizant Technology Solutions Corp. received additional deferred and restricted stock units due to dividend equivalent rights on previously held units.

Summary

  • Leo S. Mackay Jr., a director at Cognizant Technology Solutions Corp., received additional deferred and restricted stock units on February 28, 2024.
  • These units were granted as dividend equivalents on previously outstanding deferred and restricted stock units.
  • Mackay Jr. received 17.2959 deferred restricted stock units and 13.5801 restricted stock units.
  • The deferred restricted stock units are fully vested and will be settled upon Mackay Jr.'s termination of service from the Board.
  • The restricted stock units will vest fully on June 6, 2024.
  • Each unit represents a right to receive one share of Cognizant's Class A Common Stock.

Sentiment

Score: 6

Explanation: The document is neutral in tone, simply reporting a transaction related to director compensation. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Positives

  • The granting of additional restricted stock units to a director aligns their interests with those of the shareholders.
  • The dividend equivalent rights policy provides additional compensation to non-employee board members.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Management Comments

  • The Board of Directors has determined that all dividend equivalent rights on outstanding and any future restricted stock units granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms (including vesting and settlement) as the restricted stock units to which they relate.

Industry Context

Granting stock-based compensation to board members is a common practice in the technology industry to incentivize and align their interests with the company's long-term success.

Comparison to Industry Standards

  • Companies like Accenture, Infosys, and Tata Consultancy Services also utilize stock-based compensation for their board members.
  • The specific terms and amounts of these grants can vary based on company size, performance, and industry practices.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Dividend Equivalent Rights PolicyThe Board of Directors has determined that all dividend equivalent rights on outstanding and any future restricted stock units granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms (including vesting and settlement) as the restricted stock units to which they relate.09/07/2023This policy change provides additional compensation to non-employee board members in the form of restricted stock units.

Stakeholder Impact

  • Shareholders may view the granting of additional restricted stock units as a positive sign, aligning the director's interests with the company's performance.
  • Employees are not directly impacted by this transaction.

Key Dates

DateDescription
09/07/2023Record date on or after which dividend equivalent rights on restricted stock units granted to non-employee board members will be credited in the form of additional restricted stock units.
02/28/2024Date of transaction: Leo S. Mackay Jr. received deferred and restricted stock units.
03/01/2024Date of signature for the Form 4 filing.
06/06/2024Vesting date for the restricted stock units.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.